Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The updates include new information on optimizing therapy, dealing with virological failure and managing opportunistic infections.
Monitoring viral load and CD4 count can show how well treatment is working.
Larger studies suggest people living with HIV might have a modestly higher risk of severe COVID-19, but much remains to be learned.
My most recent labs revealed a record high CD4 count. Could isolation due to COVID-19 concerns be the culprit?
A discussion led by POZ founder Sean Strub about the early days of AIDS research.
HIV itself doesn’t raise the risk of getting the new virus, but some HIV-positive people are prone to severe illness.
But even starting antiretrovirals with a high CD4 count doesn’t close the wide gap in years lived without major health problems.
They’re the 2019 recipients of amfAR’s Mathilde Krim Fellowship in Basic Biomedical Research.
Of particular concern is the considerable proportion of HIV-positive women not getting viral load and CD4 tests often enough.
Expanded access study confirms the long-acting monoclonal antibody works well in people with extensive prior treatment.
Any HIV cure on the horizon will have to tackle macrophage immune cells as well as CD4 T Cells, a study indicates.
HIV-positive people with a higher viral load over a longer period appear more likely to develop hepatocellular carcinoma.
According to a systematic review and meta-analysis of dozens of studies, people with HIV have high rates of cardiac dysfunction
A study finds that CD4 cells decline after people with HIV contract hepatitis C.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.